Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

FEB 26, 2013 - Kansas City Star

A Must Read - Share

FDA halts Amgen study after teen patient death

Federal health regulators say they have halted Amgen's studies of its thyroid drug Sensipar after the death of a 14-year-old patient in a company trial.

Tags: FDA halts Amgen study after teen patient death,  Amgen Latest News